Short-term Peginterferon-Induced High Functional Cure Rate in Inactive Chronic Hepatitis B Virus Carriers With Low Surface Antigen Levels

BACKGROUND: None of the current guidelines recommend antiviral therapy for inactive hepatitis B virus (HBV) carriers (IHCs). METHODS: In this real-world, multicenter, nonrandomized study, 32 participants meeting the inclusion criteria were enrolled 1:1 for treatment with peginterferon α-2b or monito...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qing-Lei, Yu, Zu-Jiang, Shang, Jia, Xu, Guang-Hua, Sun, Chang-Yu, Liu, Na, Li, Chun-Xia, Lv, Jun, Liu, Yan-Min, Liang, Hong-Xia, Li, Zhi-Qin, Pan, Ya-Jie, Hu, Qiu-Yue, Li, Wei, Zhang, Da-Wei, Wang, Fu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324053/
https://www.ncbi.nlm.nih.gov/pubmed/32626791
http://dx.doi.org/10.1093/ofid/ofaa208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324053/
https://www.ncbi.nlm.nih.gov/pubmed/32626791
http://dx.doi.org/10.1093/ofid/ofaa208

Ejemplares similares